January 2025
- An Attribution of Value Framework for Combination Treatments
- Unpaid Caring and Health-Related Quality of Life: Longitudinal Analysis of Understanding Society (the UK Household Longitudinal Survey)
- A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines
- Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data: A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice
- Development of a Health-State Classification System for the Pediatric Quality-of-Life Inventory Version 4.0 Generic Core Scales for Preference-Based Valuation in Australia
February 2025
- Measurement Equivalence of Standard and Zoom-Enabled Electronic Clinical Outcome Assessments: Implications for Patient Accessibility in Clinical Trials
- Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report
- Value Framework Based on Multiple-Criteria Decision Analysis for Assessment of New Health Technologies Under Universal Healthcare Coverage System in Taiwan
- Healthcare Costs in the United States by Demographic Characteristics and Comorbidity Status
- Modeling the Potential Health, Health Economic, and Health Inequality Impact of a Large-Scale Rollout of the Drink Less App in England
March 2025
- Maternal Mental Health Spillovers From Child Illness and Disability: A Dynamic Panel Analysis
- Prevalence of Immature Survival Data for Anticancer Drugs Presented to the National Institute for Health and Care Excellence Between 2018 and 2022
- Economic Evaluation of 9 Intersectoral Strategies to Improve Youth Mental Health and Alleviate Financial Burden in Colombia Using System Dynamics Modeling
- The Psychometric Properties of the EQ-HWB and EQ-HWB-S in Patients With Breast Cancer: A Comparative Analysis With EQ-5D-5L, FACT-8D, and SWEMWBS
- Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis
April 2025
- How Do Bundled Payment Initiatives Account for Differences in Patient Risk Profiles? A Systematic Review
- Role of Health Equity in Health Technology Assessment Processes: A Landscape Analysis of 13 Health Systems in Asia
- IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease
- Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia
May 2025
- Public Health Supports Whole Health
- Taking Health Economics and Outcomes Research Forward: Expanding the Definition of Value to Include Whole Health
- Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products
- What Does "Whole Health" Really Mean for Health Economics and Outcomes Research?
- The Price Effects of Biosimilars in the United States
- Whole Health: A Global Perspective
- A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review
June 2025
- Quantifying Low-Value Care in Germany: An Observational Study Using Statutory Health Insurance Data From 2018 to 2021
- Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report
- Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies
- The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level
July 2025
- The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care
- Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions
- Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy
- Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review
August 2025
- Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study
- A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review
- Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity
- Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports
September 2025
- Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe
- Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study
- Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies
- Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations
October 2025
- Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel
- Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare
- Cost per Opioid-Free Year: A Systematic Review and Summary Analysis
- Meaningful Score Differences and Meaningful Score Regions of the Patient-Reported Outcomes Measurement Information System® Pediatric Asthma Impact Scale
November 2025
- ELEVATE-GenAI: Reporting Guidelines for the Use of Large Language Models in Health Economics and Outcomes Research: An ISPOR Working Group Report
- A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report
- How Similar Is Similar Enough? Assessment of Indirect Treatment Comparisons to Support Similarity for National Institute for Health and Care Excellence’s Cost Comparison Route
- Development and Use of Cognition Bolt-Ons for the EQ-5D-3L and EQ-5D-5L: A Systematic Review
- An Assessment of the Maturity of Cancer Survival Data Used in Economic Models for the National Institute for Health and Care Excellence’s Single Technology Appraisals
December 2025
- EQ Health and Wellbeing EQ-HWB: A Psychometric Assessment Across 6 Conditions and the General Population in the United Kingdom
- Zero Dollar Copay Pharmacy Benefit Decreases Healthcare Expenditures Among Members With Type 2 Diabetes of Blue Cross Blue Shield of Louisiana
- APPRAISE: A Tool for Appraising Potential for Bias in Real-World Evidence Studies on Medication Effectiveness or Safety